| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1520042A2 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/06/2005 | EP1520041A2 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 04/06/2005 | EP1520040A2 Microarrays displaying encoded molecules |
| 04/06/2005 | EP1520039A2 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis |
| 04/06/2005 | EP1520032A2 Lung cancer therapeutics and diagnostics |
| 04/06/2005 | EP1520030A1 Microorganisms and processes for enhanced production of pantothenate |
| 04/06/2005 | EP1520028A2 Compositions and methods for improving plant performance |
| 04/06/2005 | EP1520027A1 PURIFICATION, CLONING AND BIOCHEMICAL CHARACTERIZATION OF XendoU, ENDORIBONUCLEASIC ACTIVITY INVOLVED IN SMALL NUCLEAR RNA SPLICING-INDEPENDENT BIOSYNTHESIS IN XENOPUS LAEVIS |
| 04/06/2005 | EP1520026A1 Nucleic acid sequence coding for enzyme delta-12-desaturase and originating from fragilariopsis cylindrus, associated polypeptide, and use of this nucleic acid sequence and polypeptide |
| 04/06/2005 | EP1520025A2 Nucleic acid molecules involved in the synthesis of melithiazols |
| 04/06/2005 | EP1520024A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 04/06/2005 | EP1520023A2 Human nuclear hormone receptor |
| 04/06/2005 | EP1520022A2 Rna-interference by single-stranded rna molecules |
| 04/06/2005 | EP1520021A2 Antisense modulation of lrh1 expression |
| 04/06/2005 | EP1520020A2 Transposon |
| 04/06/2005 | EP1520019A2 Adapter-directed display system |
| 04/06/2005 | EP1520017A2 Subtilases and subtilase variants having altered immunogenicity |
| 04/06/2005 | EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/06/2005 | EP1520013A1 Nucleotide sequences that encode deregulated phosphoglycerate dehydrogenases of coryneform bacteria and method for producing l-serine |
| 04/06/2005 | EP1520010A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 04/06/2005 | EP1519959A2 Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519951A2 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/06/2005 | EP1519949A1 Variants of the house dust mite allergen der f2 |
| 04/06/2005 | EP1519948A1 Gene for increased somatic recombination |
| 04/06/2005 | EP1519946A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/06/2005 | EP1519942A2 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 04/06/2005 | EP1519755A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519741A2 Proteins associated with cells growth, differentiation and death |
| 04/06/2005 | EP1519736A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 04/06/2005 | EP1519725A2 Methods for targeting quadruplex dna |
| 04/06/2005 | EP1519650A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 04/06/2005 | EP1423508A4 Protein phosphatase stress-related polypeptides and methods of use in plants |
| 04/06/2005 | EP1420630A4 Stress-related polynucleotides and polypeptides in plants |
| 04/06/2005 | EP1412530A4 Ratio-based oligonucleotide probe selection |
| 04/06/2005 | EP1407050A4 Method for rapid amplification of dna |
| 04/06/2005 | EP1401260A4 A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant |
| 04/06/2005 | EP1352080A4 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 04/06/2005 | EP1341934A4 Improved biochip |
| 04/06/2005 | EP1326983B1 Gene cluster for ramoplanin biosynthesis |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1278761B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 04/06/2005 | EP1244776B1 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 04/06/2005 | EP1230345A4 Environmental stress tolerance genes |
| 04/06/2005 | EP1224469B1 Method of screening for inhibitors of asp2 |
| 04/06/2005 | EP1224304A4 Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1179076B1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 04/06/2005 | EP1165823A4 cDNA SYNTHESIS IMPROVEMENTS |
| 04/06/2005 | EP1162993B1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2005 | EP1097234B1 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) |
| 04/06/2005 | EP1040190B1 Serine proteinase inhibitors |
| 04/06/2005 | EP1003873B1 Increasing production of proteins in gram-positive microorganisms |
| 04/06/2005 | EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0793727B1 Production of variant nisin |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | EP0663013B1 Method for delivering nucleic acids into cells |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604967A Isolation tool for viable c-kit expressing cells |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604964A Ashbya gossypii enzymes |
| 04/06/2005 | CN1604963A Method for the in vitro synthesis of short double stranded RNAs |
| 04/06/2005 | CN1604960A 表达系统 Expression System |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604907A Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus DNA polymerase I variants |
| 04/06/2005 | CN1604906A Antisense antiviral agent and method for treating ssRNA viral infection |
| 04/06/2005 | CN1604905A 重组牛凝血酶 Recombinant bovine thrombin |
| 04/06/2005 | CN1604795A Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/06/2005 | CN1604789A Thymosin augmentation of genetic immunization |
| 04/06/2005 | CN1604783A Drug for treating a fibrotic disease through rna interfence |
| 04/06/2005 | CN1604735A Method of preparing eggs for nuclear transfer and uses thereof |
| 04/06/2005 | CN1603837A Device for detecting interaction between matters using capillary tube, and its using method and bioassay ground substance |
| 04/06/2005 | CN1603827A Process for chemical modification of microcapsule algal toxin LR and complete antigen synthesis |
| 04/06/2005 | CN1603418A Method for preparing infective hog cholera virus cDNA carrier and use thereof |
| 04/06/2005 | CN1603417A Human tyrosinase expression carrier and its use |
| 04/06/2005 | CN1603416A Recombinant monellin suitable to express in yeast and method for preparing same |
| 04/06/2005 | CN1603415A Fusion expression method of mycobacterium tuberculosis ESAT-6 protein in pichia |
| 04/06/2005 | CN1603414A Tobacco mitogen-activated protein kinase gene |
| 04/06/2005 | CN1603413A Cotton anaerobic enolase protein encoding sequence |
| 04/06/2005 | CN1603412A Gene sequence for lotus root chalcone synthase and its use |
| 04/06/2005 | CN1603411A Cotton ethylene response element binding factor protein encoding sequence |
| 04/06/2005 | CN1603410A DNA sequence encoding polypeptide with salt tolerance, salt resistant polypeptide SING-22 and expression carrier |
| 04/06/2005 | CN1603409A Plant promoter and its application |
| 04/06/2005 | CN1603408A Method for time delete of specific exogenous gene using induction site-specific recombination system |
| 04/06/2005 | CN1603404A Oncolytic adenovirus with target for liver cancer and its preparation method and use |
| 04/06/2005 | CN1603346A Protein, products containing same, and their use in diagnosis, treatment and /or prevention of SARS related disease |
| 04/06/2005 | CN1603345A Trivalent bispecific antibody and its preparation process and use |
| 04/06/2005 | CN1603343A Method for preparing thrombopoietin |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1603341A Human calcium ion / calmodulin deopendent protein kinase II inhibitory protein alpha, its coded sequence and use |
| 04/06/2005 | CN1603332A Osmoregulatory gene and protein and their preparation method and use |
| 04/06/2005 | CN1602962A Complete virus gene engineering vaccine of aftosa and its preparation method |